DENVER, February 28, 2023 (Newswire.com)
-
Sana Packaging - a sustainable cannabis packaging brand - has reclaimed over half a million pounds of ocean-bound plastic.
Sana Packaging launched its first reclaimed ocean-bound plastic cannabis packaging product in 2019. The company now produces six ocean-bound plastic products and has reclaimed over 550,000 pounds of ocean-bound plastic.
"None of this would be possible without our customers," said Sana Packaging Co-Founder & CEO, Ron Basak-Smith. "Thanks to the support of our incredible customers, we have diverted and reclaimed over half a million pounds of ocean-bound plastic. This is a huge milestone for Sana Packaging and we look forward to watching this number continue to grow."
All of Sana Packaging's reclaimed ocean-bound plastic cannabis packaging products are recyclable, child-resistance certified, food-grade certified, and made in the USA. Sana Packaging also offers custom printing and labeling services.
About Sana Packaging: Sana Packaging's mission is to reduce the impact of single-use packaging by leading the cannabis industry toward a sustainable future. All Sana Packaging products are made using plant-based, reclaimed, or recycled materials. Sana Packaging is a "Made in the USA" company.
AmericanGambling announced the release of a new website. The platform targets new, passionate, and experienced gamblers, who want to explore US online gaming in a safe, legal and responsible way.
WILMINGTON, Del., February 28, 2023 (Newswire.com)
-
AmericanGambling is proud to announce its launch and the availability of the website to visitors all around the USA. The aim of this platform is to provide high-quality advice on responsible gambling, U.S. gambling laws, casino payment systems and reviews of various U.S. licensed platforms.
The company understands how important making informed choices can be when it comes to online gambling so AmericanGambling wants to make sure its readers are receiving all they need to make wise decisions. Customers can expect detailed expertise from trusted professionals in the industry as well as reliable recommendations on legal aspects of gambling activities across the country.
AmericanGambling operates under official licenses.
Company received affiliate licenses in several states:
New Jersey, license #0093551, active as of Dec. 28, 2021
Michigan, license #007931, active as of April 25, 2022
Virginia, license #V-1656-101859, active as of May 01, 2022
Colorado, license #95261992, active as of May 19, 2022
On AmericanGambling, readers can only find information about fully legal brands revised by authorities such as NJ Casino Control Commission, Michigan Gaming Control Board and other state representatives.
The main goal of AmericanGambling is to provide the latest and most accurate information about gambling in the U.S.
The plan is to assist the website's readers in a variety of aspects:
Learn from non-biased evaluations, reviews, and comparisons
Learn about legal gambling activities in a particular state
Find solutions for payouts, confidentiality issues, and other problems with online gambling
Get casino reviews from real players
Get informed with the latest news from the gambling industry
Find support for gambling addiction
Learn about games and develop strategies
AmericanGambling is ready for the challenge in the U.S. online gambling market.
AmericanGambling targets only the states where some form of online gambling is already legal, or where all mainstream casino activities are available. The platform also monitors current information about the availability of legal gambling activities in various states and updates the selection for the readers. Currently, the website provides information about online casinos in several states:
Pennsylvania
New Jersey
West Virginia
Michigan
Delaware
The services provided by the company do not promote or encourage gambling; rather, the purpose is to inform customers on best practices for engaging responsibly with their chosen activities. These consultations can help facilitate a healthy relationship between individuals and their gambling habits while minimizing risk and maintaining safe boundaries at all times.
Everyone interested in receiving the services of AmericanGambling is welcome to visit their website or contact them directly via email at [email protected]. Their team is looking forward to helping customers make wiser choices when it comes to various gambling activities throughout the USA.
Contact Information:
Paul Parish
Editor-in-Chief, AmericanGambling [email protected]
Proven operational efficiencies via superior product management and an innovative health data fabric platform offer opportunities for improvements in public sector health.
SILVER SPRING, MD and TORONTO, ON, February 28, 2023 (Newswire.com)
-
BDR Solutions LLC, a service-disabled veteran-owned small business (SDVOSB) in data quality for the U.S. public sector, and Smile Digital Health, a leading health data and integration platform, today announced their new partnership. This collaboration will allow for improvements in health and wellness by streamlining and modernizing the deployment of interoperable data fabrics to agencies and public sector customers in the United States.
BDR and Smile's partnership streamlines inefficiencies traditionally caused by the integration of incompatible healthcare data management systems such as EHRs with non-standardized processes and data flows. The BDR and Smile solution is aligned with federal requirements for standards based FHIR® technology and introduces next-generation healthcare record compatibility with a competitive aftermarket ecosystem into a market notorious for incompatible data silos. While lossy, quirky data have become an expectation of medical information executives, BDR and Smile have recognized that as app and device data volume continue to expand, compatibility of U.S. information systems is a critical challenge that can no longer be postponed.
"Technologists tend to oversimplify the root problems of healthcare interoperability as technical gaps, while executives often overemphasize policy and operational issues. Interoperability in practice is an inseparable combination of both. This is why partnerships like BDR's public sector services and Smile Digital Health's product catalog are sorely needed. Both operational expertise and the right products are required to see true innovation in healthcare," said Dr. Preston Lee, BDR Vice President of Data and Innovation.
BDR improves American lives through the digital transformation of government systems and data. Through partnerships with Government customers in civilian, defense, health, and intelligence communities, BDR has become a go-to resource for technology and business process adaptation. BDR provides product management and development, systems optimization and operations, and Agile management driven by relentless commitment to innovation, customer-centricity, and time to value.
"Combining BDR's operational experience and capabilities with Smile's data fabric platform is forged from lessons learned and observations as part of federal modernization and interoperability programs. We've built the go-to-market partnership between BDR and Smile Digital Health on a baseline of trust, specifically organized to service nuanced US federal customers by combining an SDVOSB as the lead integrator with a dedicated product and team," said George Rollins, President of Smile Digital Health. "The U.S. Federal sector has demonstrated a great need for a secure, scalable, and reliable open standards health data fabric platform that eliminates costly and inflexible vendor and technology lock. Our partnership with BDR and Smile's cloud-agnostic FHIR platform serves as an antidote to this long-term risk."
Smile's HDF platform uses industry-leading HDF architecture and ONC-compliant, event-driven FHIR APIs to allow healthcare providers, payers and IT vendors to build secure, composable and scalable data infrastructures. Smile offers a suite of health data, clinical reasoning and marketplace utilities that can support ecosystem-wide data innovation and digital modernization efforts to accelerate healthcare innovation, improve quality of patient care journeys, boost operational efficiencies and reduce costs using intelligent automation implementation strategies.
###
About Smile Digital Health
Smile Digital Health is a health information technology company focused on delivering better global health through open standards. Our enterprise-grade, open framework data fabric and integration platform fuels healthcare's digital transformation and accelerates value creation across all patient journeys at scale. Powered by our HL7® FHIR® standard-based clinical data repository (#SmileInside), our platform enables collaboration and allows organizations to ingest, transform, store, enrich, analyze, aggregate and meaningfully share the health information to power digital transformation. We prepare healthcare providers, payers, researchers and life sciences organizations for a connected future beyond legacy systems, adding new value through intelligent use of information and ultimately delivering better patient outcomes. For more information visit: SmileDigitalHealth.com.
About BDR Solutions
Following 24 years of Navy service, Bob Rowe founded BDR Solutions in 2016 to improve healthcare outcomes, administrative efficiency, and patient experience for veterans, focusing on IT Transformation & Modernization, Data and Business Analytics, Agile Product Development, and System Operations. BDR offers prime access to a wide variety of contract vehicles, blanket purchase agreements, schedules, and is eligible to receive 8(a), SDVOSB, and HUBZone direct and sole source awards per the FAR. For more information, visit https://www.bdrsolutionsllc.com.
Contact Information:
Chris Kim
Vice President of Growth, BDR Solutions [email protected]
The Top 100 Registry is an annual award that recognizes outstanding women in business, industry, and professions across the United States. The selection process is rigorous and based on the nominee's professional achievements, leadership qualities, and community involvement.
BOCA RATON, Fla., February 28, 2023 (Newswire.com)
-
Claudia Bartra has been named the Top 100 Registry Woman of the Year in 2023 in recognition of her outstanding efforts and achievements in the field of finance. This award recognizes the achievements and contributions of women in various industries and professions, and this is the second year Claudia Bartra has received Top 100 Registry Woman of the Year.
The Top 100 Registry is a prestigious annual award that recognizes outstanding women in business, industry, and professions across the United States. The selection process is rigorous and based on the nominee's professional achievements, leadership qualities, and community involvement.
Claudia Bartra is a highly accomplished professional in her field, with a track record of success in business, industry, and community service. Her dedication to excellence and commitment to making a positive impact on the lives of others is truly inspiring. Bartra is actively involved in the community, notably as CFO of LifeGaines Medical and CBartra Investments, and CFO of La Granja, her successful chain of award-winning Peruvian restaurants. Her philanthropic contributions include her work with ASPIRA, a youth organization for Latin American children, providing scholarships to students attending Palm Beach State College, and being honored for her support of children's education both in the United States and her home country of Peru. Bartra deeply values the power of education and also partners with Fusion Academy to confront the nationwide problem of bullying and provide a resource for students where they can feel comfortable in addressing their concerns to their parents and teachers.
"I am honored to be recognized as the Top 100 Registry Woman of the Year for 2023," said Claudia Bartra. "I am grateful for this recognition and will continue to work hard to make a positive impact in my industry and community."
Claudia Bartra is a role model for women in business and a shining example of what can be achieved through hard work, dedication, and a passion for making a difference.
About Top 100 Registry
Top 100 Registry is a leading global publisher of industry-specific magazines featuring top professionals in the fields of Law, Academia, Medicine, Consulting, Arts, Sciences & beyond. They recognize individuals for their contributions to their industries and professions. For more information, please visit https://www.top100registry.com.
For more information about Claudia Bartra and her achievements, please visit her website at https://claudiabartra.com.
SNOHOMISH, Wash., February 28, 2023 (Newswire.com)
-
Joe Kennedy, the 18-year Marine veteran whose court battle was taken all the way in 2022 to the Supreme Court, which ruled in favor of him and his First Amendment right to offer prayers of thanks at the end of football games he coached for Bremerton High School, will be the Keynote Speaker at the Resolve Men's Conference on March 10 and 11 at The House Ministry Center in Snohomish, WA. Coach Joe will be speaking on the topics of Religious Freedom and Leading Courageously. Additional speakers include former MLB player Steven Souza Jr., Coach Mike Connaway, Daniel Ritchie, DJ Rabe, and one of America's top inspirational comedians, Nazareth.
Coach Kennedy was an assistant coach for the BHS varsity football team. Before he even coached his first game, the Marine-turned-football coach made a commitment to God that he would give thanks at the conclusion of each game for what the players had accomplished and for the opportunity to be part of their lives through football. This was met with disapproval from his school district and turned into a lengthy court battle. On June 27, 2022, the Supreme Court ruled in favor of Coach Kennedy and his First Amendment right. He looks forward to being reinstated and returning to the field. A film inspired by his life is in development. He continues to speak across the country, promoting freedom of speech.
LAS VEGAS, February 28, 2023 (Newswire.com)
-
Gentleman's Guru, the gold standard in high-end men's formal wear, is excited to announce the launch of its new collection of exotic prom suits and luxury prom tuxedos. This collection features handcrafted garments embroidered with intricate designs and made with the finest materials.
The collection also includes a variety of styles, including shawl and peak lapel suits, as well as slim-fit and custom-sized options to ensure a perfect fit for every customer. The collection is designed to cater to the most discerning tastes, with styles that are truly one-of-a-kind and can't be found anywhere else.
"We are thrilled to unveil our new collection of prom suits and tuxedos," said Yassine Lamari, CEO of Gentleman's Guru. "We understand that prom is a special occasion, and we want to ensure our customers look their best. Our new collection is designed to give prom kings the style and elegance they deserve."
The collection is available for purchase now on the Gentleman's Guru website.
Gentleman's Guru is committed to providing customers with the highest quality formal wear and the best possible customer service. The company has built a reputation for excellence over the years, and its new collection of prom suits and tuxedos is no exception.
For more information about Gentleman's Guru's new collection of prom suits and tuxedos or to purchase online, please visit the company's website at https://www.gentlemansguru.com.
About Gentleman's Guru:
Gentleman's Guru is the gold standard of high-end men's formal wear. The company offers a wide range of suits, tuxedos, and accessories for all formal occasions. With a commitment to quality and customer service, Gentleman's Guru has established itself as one of the premier formal wear providers in the industry.
An Interview with Chief Technology Officer (CTO) John Cray
NORTH AURORA, Ill., February 28, 2023 (Newswire.com)
-
Mental Health Technologies (MHT) offers a rapidly growing cloud-based platform primary care physicians and mental health professionals use to screen and test for mental health disorders, including depression and substance abuse. MHT helps providers identify areas where their patients are struggling and refers them to the proper behavioral healthcare professional.
In a recent interview, MHT's CTO, John Cray, talks about how their technology is different and discusses the company's newest innovation:
What is SmarTest?
SmarTest is a tool that uses intelligence and historical data to define when—and how—a patient should be tested for various mental health conditions. It can base its decisions on patient information, such as age, gender, or other demographics. Every clinic or provider group can define its own rules for how SmarTest works.
A clinician may test patients on a particular treatment regimen for depression every three months, but those who indicate severe depression may require more frequent measurement. A primary care practice may test all patients once per year for certain conditions but use the assessment results to automate the referral of certain patients to mental health providers.
How do you work with evolving needs of clients?
Our company understands that we need to be receptive to feedback so that we can maximize our value and help in any way we can. We continuously meet with our current and prospective clients to plan what we do next to make the most of our services.
For example, based on the need to get new tests into the system as quickly as possible, we developed a wizard that allows us to create a new test in a matter of minutes. We can very quickly enhance clinic-specific or standardized tests. This level of flexibility is unique to us, as well.
We also recently released a new feature that can automatically route them to a webpage that is optimized to help them. If a patient indicates suicidality, they can be directed immediately to the 988 suicide lifeline page. Or if the patient answers above a certain score depression level, we can route them to a page describing advanced treatment options for them.
How are you measuring MHT's success?
MHT saw a 20% growth rate in 2022. In the month of January 2023 alone, we grew an additional 20%. We use our data to measure our own success and drive our focus. And we are also working to use this data to provide valuable analytics to our customers.
Clinics can compare their own results to benchmark data across the industry by whatever metric they desire. MHT can report on whether a practice's patients are improving faster or slower than similar patients across the country. The data itself is a goldmine of information for decision-making.
Contact Information:
Ernie Wallerstein
CEO [email protected]
6402400323
ForCast Orthopedics Receives Qualified Infection Disease Product (QIDP) Designation from FDA for the Treatment of Periprosthetic Joint Infection (PJI)
DENVER, February 28, 2023 (Newswire.com)
-
ForCast Orthopedics today announced that the US Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) Designation for ForCast's lead program, FC001, for the treatment of periprosthetic joint infection (PJI).
PJI is a rare but serious complication of joint replacement procedures that can threaten the function of the joint, the preservation of the limb and even the life of the patient. PJI is challenging to treat because the infecting bacteria adhere to the prothesis and form a protective biofilm that can be resistant to standard systemic antibiotics.
FC001 is being developed to address these challenges by delivering a targeted antibiotic therapy directly into the infected joint using ForCast's proprietary technology.
QIDP designation, provided under the Generating Antibiotic Incentives Now Act (GAIN Act), offers certain incentives for the development of new antifungal and antibacterial drugs that treat serious or life-threatening infections. These incentives include Fast Track designation, priority review, and additional market exclusivity if the product is approved by the FDA.
"We are very pleased to receive QIDP designation from the FDA," said Peter Noymer, PhD, Executive Chairman and CEO of ForCast Orthopedics. "This represents an important milestone for the company as we progress our lead product through development and toward commercialization."
"This is an exciting step forward for ForCast," added Jared Foran, MD, Chief Scientific Officer and co-founder of ForCast Orthopedics, "and one that validates our commitment to making better therapies available sooner for PJI patients."
About ForCast Orthopedics
ForCast is a development-stage company with a focus on pioneering the treatment of periprosthetic joint infection (PJI) with targeted antibiotic therapy. Our mission is to modernize the standard of care for PJI and improve the quality of life for the growing population of joint replacement patients.
Contact Information:
Peter Noymer
Executive Chairman and CEO [email protected]
SAN FRANCISCO, February 28, 2023 (Newswire.com)
-
KlimaDAO is an on-chain scaling solution for the Voluntary Carbon Market. KlimaDAO aims to open up the market to greater transparency and efficiency by combining digital carbon with a blockchain-enabled technology stack.
Silverpine is a fintech platform that enables greater access to alternative investment products, including collectible cars. Silverpine's mission is to democratize access to alternative investments through fractional ownership. Historically, high-value assets such as collectible cars have been out of reach for much of the market; however, by leveraging novel tools developed using digital technologies, Silverpine can now change this and enable greater participation in the alternative investment space.
The entire automotive sector is required to consider its carbon footprint and strive to achieve carbon neutrality over the coming years. Silverpine as a part of this industry with the tokenization of collectible cars, has partnered with KlimaDAO to demonstrate carbon neutrality can be achieved efficiently and transparently.
KlimaDAO is developing public and transparent infrastructure that allows the sourcing and offsetting of carbon credits to be achieved on the blockchain - meaning that all offsetting can be traceable and verifiable. To this end, through this collaboration, KlimaDAO and Silverpine have partnered to offset the emissions associated with the EVO II's expected lifetime emissions - equalling 76 tonnes of carbon dioxide.
KlimaDAO has produced a certificate that is tied to the EVO's unique vehicle identification number; this enables the carbon offset to be verified and attributed to the EVO. The carbon credits used represent the environmental benefit from investments made at the Solar Power Project by SolarArise India Projects Pvt. Ltd.
Scan the QR on the image to see the proof of carbon offset.
Silverpine and KlimaDAO share a vision for more transparent and accessible markets for all, and this collaboration demonstrates how this technology can bring real benefits to consumers.
About Silverpine
Silverpine is a fintech platform for alternative investment, making unique collectible cars accessible through fractional ownership. Allowing people to own a piece of an iconic car without the hassle of storage and maintenance.
KlimaDAO's mission is to accelerate the delivery of climate finance globally by building the transparent, neutral, and public infrastructure needed to scale the Digital Carbon Market. Contact KlimaDAO.
PARIS, FRANCE, February 28, 2023 (Newswire.com)
-
On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced the launch of two ambitious programs to develop and validate novel digital biomarkers for the self-assessment of patients suffering from generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorders (NMOSD). The programs will leverage assets, methodologies and expertise built by Ad Scientiam over the past five years and are supported by Alexion, AstraZeneca Rare Disease.
gMG and NMOSD are chronic severe diseases in which progression is complex and critical to monitor. The course of NMOSD is driven by episodes of severe, sequential relapses leading to the accrual of permanent disability, while gMG is characterized by a heterogeneous collection of symptoms (including fatigue and muscle group weakness) which fluctuate over time.
Currently, no objective measurement tools exist to allow gMG and NMOSD patients to track their symptoms over time. Digital biomarkers are patient-generated physiological and behavioral measures that are collected from digital devices like smartphones and processed by algorithms. If clinically validated, these measures could provide data to improve the remote monitoring of disease symptoms.
"We believe that empowering patients through real-time digital data sharing could strengthen communication between patients and healthcare professionals, and may enable more informed disease management decisions," said Dr. Guido Sabatella, Global Medical Lead in Neurology at Alexion.
"Easy-to-use digital tools have the potential to generate reliable and objective data to better understand the real impact of the disease on patients' lives and also have the potential to demonstrate the benefits of novel therapies to keep disease under control," explains Matthieu Lamy, Ad Scientiam's President.
Scoping phases have been conducted for both programs to identify clinically meaningful digital biomarkers to monitor patients living with NMOSD or gMG. Ongoing research will inform the development of a digital medical device intended to be used by patients as a self-assessment tool.
"International, multicenter, comparative studies against clinical gold standards, such as the Quantitative Myasthenia Gravis score and assessments of visual function, ambulation and dexterity in NMOSD, will be deployed to confirm the clinical relevance of selected digital biomarkers," according to Dr. Saad Zinaï, Ad Scientiam's Chief Medical Officer.
About Ad Scientiam
We strongly believe that continuously monitoring the progression of severe and disabling diseases in real life is crucial for delivering better care.
To achieve this, we create and clinically validate digital biomarkers that make visible these previously undetectable changes. These biomarkers are developed using data collected through smartphones and transformed using proprietary algorithms.
Hospital institutions such as the Paris Brain Institute (ICM) and pharmaceutical companies, including Biogen, Janssen, Roche, Pfizer, Vertex, and Novartis, trust us. In 2019, we launched MSCopilot®, the first CE-marked software medical device for the self-assessment of patients with multiple sclerosis. We are currently validating new devices in neuroscience, rare diseases, and mental disorders. Ad Scientiam is ISO 13485 certified.
